Abstract
Purpose
Conditional survival (CS) provides a dynamic prediction of patient survival by incorporating the time an individual has already survived given their disease specific characteristics. The objective of the current study was to estimate CS among patients after surgery for spinal cord compression or spinal instability, as well as stratify CS according to relevant patient- and disease-related characteristics.
Methods
The clinical outcomes of 361 patients undergoing surgical management of metastatic spinal tumors were retrospectively analyzed. Stratification of this cohort according to disease and surgery-specific characteristics allowed for univariate and multivariate statistical analyses of our study population. Observed overall and conditional survival estimates were calculated by the Kaplan–Meier method.
Results
12-month conditional survival in patients undergoing surgical management of metastatic spine tumors increased from 57% at baseline to 70% at 24 months following spine surgery. Overall survival (OS) was influenced by CCI grade, Katagiri tumor type, presence of lung metastasis, type of spine surgery, presence of postoperative systemic therapy and ambulatory status at follow-up. Analyses of OS and CS by prognostic strata were similar with exception of stratification by surgery type. Differences in survival between strata tend to converge over time. Unfavorable factors for OS appear to be less relevant after a period of 24 months following spine surgery.
Conclusion
Patients after surgery for metastatic tumors of the spine can expect a positive trend in conditional survival as survivorship increases. Even patients with a more severe disease can be encouraged with gains in conditional survival over time.
Level of evidence
Level IV (retrospective cohort study).
Similar content being viewed by others
Availability of data and material
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
The R code generated during the current study are available from the corresponding author on reasonable request.
References
Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121
Henson DE, Ries LAG (1994) On the estimation of survival. Semin Surg Oncol 10:2–6. https://doi.org/10.1002/ssu.2980100103
Henson DE, Ries LA, Carriaga MT (1995) Conditional survival of 56,268 patients with breast cancer. Cancer 76:237–242. https://doi.org/10.1002/1097-0142(19950715)76:2%3c237::aid-cncr2820760213%3e3.0.co;2-j
Hieke S, Kleber M, König C et al (2015) Conditional survival: a useful concept to provide information on how prognosis evolves over time. Clin Cancer Res Off J Am Assoc Cancer Res 21:1530–1536. https://doi.org/10.1158/1078-0432.CCR-14-2154
Zabor EC, Gonen M, Chapman PB, Panageas KS (2013) Dynamic prognostication using conditional survival estimates. Cancer 119:3589–3592. https://doi.org/10.1002/cncr.28273
Wancata LM, Banerjee M, Muenz DG et al (2016) Conditional survival in advanced colorectal cancer and surgery. J Surg Res 201:196–201. https://doi.org/10.1016/j.jss.2015.10.021
Brouwer NPM, Bos ACRK, Lemmens VEPP et al (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer 143:2758–2766. https://doi.org/10.1002/ijc.31785
Shigeta K, Kikuchi E, Hagiwara M et al (2017) The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma. J Urol 198:1278–1285. https://doi.org/10.1016/j.juro.2017.06.073
Kim Y, Ejaz A, Spolverato G et al (2015) Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative. Ann Surg Oncol 22:557–564. https://doi.org/10.1245/s10434-014-4116-5
Farah P, Blanda R, Kromer C et al (2016) Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995–2012. J Neurooncol 128:419–429. https://doi.org/10.1007/s11060-016-2127-8
Macedo F, Ladeira K, Pinho F et al (2017) Bone metastases: an overview. Oncol Rev 11:321. https://doi.org/10.4081/oncol.2017.321
Rose PS, Buchowski JM (2011) Metastatic disease in the thoracic and lumbar spine: evaluation and management. JAAOS–J Am Acad Orthop Surg 19:37–48
Gasbarrini A, Cappuccio M, Mirabile L et al (2004) Spinal metastases: treatment evaluation algorithm. Eur Rev Med Pharmacol Sci 8:265–274
Kato S, Demura S, Shinmura K et al (2021) Surgical metastasectomy in the spine: a review article. Oncologist 26:e1833–e1843. https://doi.org/10.1002/onco.13840
Katagiri H, Okada R, Takagi T et al (2014) New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 3:1359–1367. https://doi.org/10.1002/cam4.292
Kumar N, Ramos MRD, Patel R et al (2021) The “spinal metastasis invasiveness index”: a novel scoring system to assess surgical invasiveness. Spine 46:478–485. https://doi.org/10.1097/BRS.0000000000003823
Chicco D, Tötsch N, Jurman G (2021) The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min 14:13. https://doi.org/10.1186/s13040-021-00244-z
Volinsky CT, Raftery AE (2000) Bayesian information criterion for censored survival models. Biometrics 56:256–262. https://doi.org/10.1111/j.0006-341X.2000.00256.x
Zabor EC, Gonen M (2018) condsurv: conditional survival estimates and plots. R package version 1.0.0.
Rothrock RJ, Barzilai O, Reiner AS et al (2020) Survival trends after surgery for spinal metastatic tumors: 20-year cancer center experience. Neurosurgery 88:402–412. https://doi.org/10.1093/neuros/nyaa380
Wright E, Ricciardi F, Arts M et al (2018) Metastatic spine tumor epidemiology: comparison of trends in surgery across two decades and three continents. World Neurosurg 114:e809–e817. https://doi.org/10.1016/j.wneu.2018.03.091
Tobin NP, Foukakis T, De Petris L, Bergh J (2015) The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer. J Intern Med 278:545–570. https://doi.org/10.1111/joim.12429
Bilsky MH, Laufer I, Burch S (2009) Shifting paradigms in the treatment of metastatic spine disease. Spine 34:S101–S107. https://doi.org/10.1097/BRS.0b013e3181bac4b2
Kim CH, Chung CK, Jahng T-A, Kim HJ (2011) Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis. Spine J 11:1015–1023. https://doi.org/10.1016/j.spinee.2011.09.007
Yang SB, Cho W, Chang U-K (2012) Analysis of prognostic factors relating to postoperative survival in spinal metastases. J Korean Neurosurg Soc 51:127–134. https://doi.org/10.3340/jkns.2012.51.3.127
Heiden JJ, Goodin SR, Mormino MA et al (2021) Early ambulation after hip fracture surgery is associated with decreased 30-day mortality. J Am Acad Orthop Surg 29:e238–e242. https://doi.org/10.5435/JAAOS-D-20-00554
Mechas CA, Isla AE, Abbenhaus EJ et al (2022) Clinical outcomes following distal femur replacement for periprosthetic distal femur fractures: a systematic review and meta-analysis. J Arthroplasty 37:1002–1008. https://doi.org/10.1016/j.arth.2022.01.054
Myeroff CM, Anderson JP, Sveom DS, Switzer JA (2018) Predictors of mortality in elder patients with proximal humeral fracture. Geriatr Orthop Surg Rehabil 9:2151458517728155. https://doi.org/10.1177/2151458517728155
Muraki S, Yamamoto S, Ishibashi H, Nakamura K (2006) Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab 24:100–104. https://doi.org/10.1007/s00774-005-0654-z
Ahmed AK, Goodwin CR, Heravi A et al (2018) Predicting survival for metastatic spine disease: a comparison of nine scoring systems. Spine J 18:1804–1814. https://doi.org/10.1016/j.spinee.2018.03.011
Ruatta F, Derosa L, Escudier B et al (2019) Prognosis of renal cell carcinoma with bone metastases: experience from a large cancer centre. Eur J Cancer 107:79–85. https://doi.org/10.1016/j.ejca.2018.10.023
Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186–2191. https://doi.org/10.1097/01.brs.0000180401.06919.a5
Amelot A, Moles A, Cristini J et al (2016) Predictors of survival in patients with surgical spine multiple myeloma metastases. Surg Oncol 25:178–183. https://doi.org/10.1016/j.suronc.2016.05.012
Greipp PR, Miguel JS, Durie BGM et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420. https://doi.org/10.1200/JCO.2005.04.242
Santini D, Tampellini M, Vincenzi B et al (2012) Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol 23:2072–2077. https://doi.org/10.1093/annonc/mdr572
Takagi T, Katagiri H, Kim Y et al (2015) Skeletal metastasis of unknown primary origin at the initial visit: a retrospective analysis of 286 cases. PLoS ONE 10:e0129428. https://doi.org/10.1371/journal.pone.0129428
Kawamura H, Yamaguchi T, Yano Y et al (2018) Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer. Dis Colon Rectum 61:673–678. https://doi.org/10.1097/DCR.0000000000001071
Tomita K, Kawahara N, Kobayashi T et al (2001) Surgical strategy for spinal metastases. Spine 26:298–306. https://doi.org/10.1097/00007632-200102010-00016
Du Z, Guo W, Yang R et al (2016) What is the value of surgical intervention for sacral metastases? PLoS ONE 11:e0168313. https://doi.org/10.1371/journal.pone.0168313
Sioutos PJ, Arbit E, Meshulam CF, Galicich JH (1995) Spinal metastases from solid tumors. Anal Factors Affect Surv Cancer 76:1453–1459. https://doi.org/10.1002/1097-0142(19951015)76:8%3c1453::AID-CNCR2820760824%3e3.0.CO;2-T
Song K, Lin K, Guan H, Li F (2020) Conditional survival analysis for spinal chondrosarcoma patients after surgical resection. Spine 45:1110–1117. https://doi.org/10.1097/BRS.0000000000003494
Huang J-F, Chen D, Zheng X-Q et al (2019) Conditional survival and changing risk profile in patients with chordoma: a population-based longitudinal cohort study. J Orthop Surg 14:181. https://doi.org/10.1186/s13018-019-1225-7
Schirren J, Schirren M, Lampl L, Sponholz S (2017) Surgery for pulmonary metastases: quo vadis? Eur J Cardiothorac Surg 51:408–410. https://doi.org/10.1093/ejcts/ezw441
Orlandi A, Pontolillo L, Mele C et al (2021) Liver metastasectomy for metastatic breast cancer patients: a single institution retrospective analysis. J Pers Med 11:187. https://doi.org/10.3390/jpm11030187
Wibmer C, Leithner A, Hofmann G et al (2011) Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine 36:1977–1986. https://doi.org/10.1097/BRS.0b013e3182011f84
Chang SY, Chang B-S, Lee C-K, Kim H (2019) Remaining systemic treatment options: a valuable predictor of survival and functional outcomes after surgical treatment for spinal metastasis. Orthop Surg 11:552–559. https://doi.org/10.1111/os.12501
Mesfin A, Buchowski JM, Gokaslan ZL, Bird JE (2015) Management of metastatic cervical spine tumors. JAAOS–J Am Acad Orthop Surg 23:38–46. https://doi.org/10.5435/JAAOS-23-01-38
Boriani S, Weinstein JN, Biagini R (1997) Primary bone tumors of the spine. Terminol Surg Stag Spine 22:1036–1044. https://doi.org/10.1097/00007632-199705010-00020
Funding
There is no funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethics approval
The study was approved by the Hospital Institutional Review Board and complied with International Ethical Guidelines for Biomedical Research, Declaration of Helsinki, and local laws.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Patients signed informed consent regarding publishing their data and photographs.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zaborovskii, N., Schlauch, A., Shapton, J. et al. Conditional survival after surgery for metastatic tumors of the spine: does prognosis change over time?. Eur Spine J 32, 1010–1020 (2023). https://doi.org/10.1007/s00586-023-07548-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-023-07548-0